1604803
USP
Ritonavir
United States Pharmacopeia (USP) Reference Standard
동의어(들):
1,3-Thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
크기 선택
제품정보 (DICE 배송 시 비용 별도)
생물학적 소스
synthetic
Grade
pharmaceutical primary standard
Agency
USP
vapor pressure
<0.0000001 kPa ( 25 °C)
API family
ritonavir
양식
powder
포장
pkg of 200 mg
제조업체/상표
USP
저장 조건
protect from light
색상
white to tan
solubility
acetonitrile: slightly soluble
ethanol: freely soluble
methanol: freely soluble
methylene chloride: freely soluble
water: practically insoluble
응용 분야
pharmaceutical (small molecule)
형식
neat
SMILES string
[s]1c(nc(c1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@@H](NC(=O)OCc4[s]cnc4)Cc3ccccc3)Cc2ccccc2)C(C)C
InChI
1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1
InChI key
NCDNCNXCDXHOMX-XGKFQTDJSA-N
유사한 제품을 찾으십니까? 방문 제품 비교 안내
일반 설명
Ritonavir belongs to the group of protease inhibitors that are widely used in combination with other drugs in the prevention of HIV. Its mode of action involves binding to the active site of the protease enzyme and preventing the further maturation of new viral particles.
애플리케이션
- Ritonavir Capsules
 - Ritonavir Tablets
 - Ritonavir Oral Solution
 - Lopinavir and Ritonavir Tablets
 - Lopinavir and Ritonavir Oral Solution
 
분석 메모
기타 정보
신호어
Warning
유해 및 위험 성명서
예방조치 성명서
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.